编号 | 日期 | 题目 | 发表时间 | 汇报人 | 杂志名称 |
1 | 0225 | Severely polarized extracellular acidity around tumour cells | 2024.6 | 张仁璐 | Nature Biomedical Engineering |
2 | 0304 | Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti PD-1 resistance via targeting PD-L1 | 2025.1 | 闫超论 | Cancer Cell |
3 | 0311 | The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer | 2024.1 | 余畅 | Nature |
4 | 0318 | Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion | 2025.1 | 刘静 | Immunity |
5 | 0325 | The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer | 2025.3 | 翁淑萍 | Nature immunology |
6 | 0401 | Cancer cells impair monocyte-mediated T cell stimulation to evade immunity | 2025.1 | 袁鹏清 | Nature |
7 | 0408 | Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade | 2024.1 | 陈炳坤 | Science Translational Medicine |
8 | 0416 | FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity | 2025.4 | 陈燚婷 | Journal of Hepatology |
9 | 0422 | Lung adenocarcinoma promotion by air pollutants | 2023.4 | 唐国峰 | Nature |
10 | 0506 | Antigen-presenting cancer associated fibroblasts enhance antitumor immunityand predict immunotherapy response | 2025.2 | 赵延龙 | Nature Communications |
11 | 0514 | A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals | 2025.4 | 朱奎 | Science |
12 | 0520 | STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity | 2025.7 | 黄海娜 | Nature |
13 | 0527 | Immune evasion through mitochondrial transfer in the tumour microenvironment | 2025.2 | 周琳琳 | Nature |
14 | 0610 | Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis | 2025.7 | 侯平 | Cell |
15 | 0617 | Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity | 2025.4 | 邹玉莲 | Science |
16 | 0902 | Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin | 2025.6 | 朱艳阳 | Nature |
17 | 0916 | 蛋白(修饰)组学在临床研究中应用策略和最新进展 | 景杰生物赵越 | ||
18 | 0909 | Multimodal deep learning integration of cryo-EM and AlphaFold3 for high accuracy protein structure determination | 2025.10 | 康俊彪 | Communications Chemistry |
19 | 0923 | Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation | 2025.7 | 吴琼雯 | Molecular Cancer |
20 | 0930 | Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer | 2020.1 | 费萨尔 | Cell stem cell |
21 | 1021 | An oncolytic virus–T cell chimera for cancer immunotherapy | 2024.10 | 陈志宏 | Nature biotechnology |
22 | 1029 | An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy | 2024.7 | 李佩 | Nature cancer |
23 | 1105 | High fructose consumption aggravates inflammation by promoting effector T cell generation via inducing metabolic reprogramming | 2025.7 | 康艳丽 | Signal Transduction and Targeted Therapy |
24 | 1112 | Tumour-associated macrophages serve as an acetate reservoir to drive hepatocellular carcinoma metastasis | 2025.10 | 林南平 | Nature metabolism |
25 | 1119 | Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion | 2025.1 | 林艳婷 | Immunity |
26 | 1126 | Biolegend抗原特异性T细胞检测技术-FLEX-T & 单细胞蛋白组学工具-TotalSeq™抗体 | 达科为 | ||
27 | 1203 | CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success | 2025.11 | 张旭艳 | Cell |
28 | 1210 | Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity | 2025.11 | 黎剑桥 | Science |
29 | 1217 | Bile acid synthesis impedes tumor-specific T cell responses during liver cancer | 2025.1 | 林子琨 | Science |
30 | 1224 | IL-9 signaling redirects CAR T cell fate toward CD8 memory and CD4+ cycling states, enhancing antitumor efficacy | 2026.1 | 严思捷 | Immunity |
31 | 1230 | Adoptive T cell therapy targeting an inducible and broadlysharedproductofaberrantmRNAtranslation | 2025.1 | 王艺锦 | Immunity |
